Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06094569
Other study ID # TJHH-2023-wm14
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2019
Est. completion date December 31, 2029

Study information

Verified date October 2023
Source Tianjin Huanhu Hospital
Contact Ming Wei, PhD
Phone 13502182903
Email drweiming@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients with ischemic stroke in the posterior circulation continue to have high rates of mortality and disability, even with aggressive treatment. We wanted to evaluate preoperative imaging to screen patients with a good prognosis from mechanical embolization. We assess the degree of ischemia by defining the pons-midbrain-medulla index (PMMI) and correlate the preoperative PMMI with the clinical prognosis of postoperative patients to verify the validity of PMMI in predicting the clinical prognosis of patients with embolization.


Description:

- The ENDOSTROKE registry (Endovascular Stroke T reatment Registry), the use of MRI before EVT was associated with significantly better clinical outcomes as compared to CT. - The purpose of the study will sift patients with posterior circulation ischemia stroke who will get better outcome by Mechanical Thrombectomy by neuroimaging.Specifically, the following assumption will be evaluated: the modified pons-midbrain index in magnetic resonance imaging can predict the clinical outcome of patients with basilar artery thrombosis 90 days after surgery, and can guide whether patients will undergo mechanical thrombectomy later. - Pons-midbrain-medulla index (PMMI) : We divide pons-midbrain-medulla into the left and right sides by the median line of the brainstem,so we will evaluate ischemia of these six layers which are endowed different score according to the degree of ischemia. Instead of the previous pons-midbrain index (PMI), we select the image layer that shows the largest infarct size among the six parts.Then,we add up six scores that is patient's PMMI. Scoring criteria: At the layer of displaying the maximum infarct size, 2 points are scored if the infarct size exceeds 50% of the total area, 1 point is scored if the infarct size is less than 50% of the total area, and 0 points are scored if there is no infarct.Finally, PMMI values range from 0 to 12 points. - The investigators conduct a multicenter, prospective cohort study.Preoperative images of patients are evaluated by different groups of imaging physicians to describe the association between preoperative PMMI and clinical prognosis in patients with posterior circulation stroke and to verify its validity.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date December 31, 2029
Est. primary completion date December 31, 2029
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: 1. Patient admitted from Jun. 1st 2019 to Jan. 1st 2029; 2. Patients with acute ischemic stroke recently; 3. Symptoms persisted at admission, and MRI (including DWI) confirmed acute ischemic vertebrobasilar artery occlusion in the posterior circulation:(single right or left intracranial branch of vertebral artery occlusion ; single basilar occlusion ; both two vertebral arterys and basilar artery); Exclusion Criteria: 1.Patiens can not meet the MRI examination conditions(with absolute and relative contraindications).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Endovascular Therapy
Endovascular therapy, as an adjunct to standard stroke therapy, may be beneficial for a very select population of patients who present with an acute ischemic stroke and have a proven large, proximal occlusion on imaging. Endovascular therapy includes any one or more of the following: Intra-arterial thrombolytic therapy, aspiration, stent retrieval, or a combination of multiple mechanical devices

Locations

Country Name City State
China Beijing University Binhai Hospital Tianjin Tianjin
China The Sencond Hospital of Tianjin Medical University Tianjin Tianjin
China Tianjin Huanhu Hospital Tianjin Tianjin
China Tianjin Medical University General Hospital Tianjin Tianjin

Sponsors (1)

Lead Sponsor Collaborator
Tianjin Huanhu Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other National Institutes of Health Stroke Scale (NIHSS) scores at 90 days The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment. The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0. 90 days
Other Occurrence of periprocedural complications Periprocedural complications include any intracranial hemorrhage, cerebral edema, brain herniation and pneumonia. 90 days
Other pc-ASPECT (posterior circulation Alberta Stroke Program Early CT score) pc-ASPECTS is a 10-point quantitative topographic CT scan score used in patients with posterior circulation stroke. 0 days
Primary Modified ranking scale (mRS) at 90 days A 0-6 scale running from perfect health without symptoms to death. 90 days
Secondary Mortality within 90 days mortality of any causes. 90 days
See also
  Status Clinical Trial Phase
Completed NCT04484350 - Blood Pressure Management in Stroke Following Endovascular Treatment Phase 2
Recruiting NCT04121611 - Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation N/A
Recruiting NCT04517383 - Effects of Post-Operative Sedation for Endovascular Thrombectomy N/A
Enrolling by invitation NCT06361017 - The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy
Recruiting NCT05708079 - Multidimensional Evaluation of Patients With Acute Ischemic Stroke Undergoing Pharmacological and Endovascular Revascularization Procedures for the Identification of Positive Prognostic Factors
Completed NCT05684172 - Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation Phase 2/Phase 3
Completed NCT04116112 - Blood Pressure After Endovascular Stroke Therapy-II Phase 2
Completed NCT06290076 - A Predictive Model and Scoring System for Severe Complications After Endovascular Thrombectomy
Recruiting NCT05735301 - MR Imaging Selection for Endovascular Treatment in Acute Ischemic Stroke at 6 to 24 Hours N/A
Recruiting NCT06200753 - Triage of Patients Presenting Beyond 24 Hours With Acute Ischemic Stroke Due to Large Vessel Occlusions (TRACK-LVO Late)
Completed NCT04667637 - Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol Phase 2
Recruiting NCT06146790 - Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke N/A
Completed NCT06213870 - Screening of Endovascular Thrombectomy With MRI in Acute Ischemic Stroke